Key messages
- Laboratory systems as the foundation of epidemic intelligence
Deployment of more than 50 000 GeneXpert cartridges decentralized Mpox testing
far beyond central reference laboratories, while 46 of 47 Member States now have
genomic sequencing capacity. - Quality assured, performance measured
51 laboratories across 32 countries achieved an 89.4% detection success rate in the
Mpox External Quality Assessment, demonstrating regional standardization of
molecular testing. - Surveillance reaching every Member State
44 Member States participated in the IDSR assessment; weekly IDSR data
completeness reached 94% by week 52, supported by 31 meningitis bulletins and
dedicated outbreak analytics. - Faster detection, earlier action
126 new signals were detected in 2025 with a median detection-to-verification time of
one day, and approximately 74% of outbreaks were detected within seven days of
occurrence. - Intelligence powered by innovation
EIOS expanded to 44 of 47 Member States, complemented by speech-to-text radio
mining, machine learning classification, and fourfold growth in Weekly Bulletin
readership.
